SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001558370-19-002382
Filing Date
2019-03-22
Accepted
2019-03-22 16:31:14
Documents
8

Document Format Files

Seq Description Document Type Size
1 424B5 f424b5.htm 424B5 470872
2 GRAPHIC f424b5g001.jpg GRAPHIC 15958
3 GRAPHIC f424b5g002.jpg GRAPHIC 18057
4 GRAPHIC f424b5g003.jpg GRAPHIC 23845
5 GRAPHIC f424b5g004.jpg GRAPHIC 22690
6 GRAPHIC f424b5g005.jpg GRAPHIC 27284
7 GRAPHIC f424b5g006.jpg GRAPHIC 18452
8 GRAPHIC f424b5g007.jpg GRAPHIC 6418
  Complete submission text file 0001558370-19-002382.txt   655647
Mailing Address 1505 ADAMS DRIVE, SUITE D MENLO PARK CA 94025
Business Address 1505 ADAMS DRIVE, SUITE D MENLO PARK CA 94025 650-889-5020
BioPharmX Corp (Filer) CIK: 0001504167 (see all company filings)

IRS No.: 593843182 | State of Incorp.: DE | Fiscal Year End: 0131
Type: 424B5 | Act: 33 | File No.: 333-229459 | Film No.: 19700236
SIC: 2834 Pharmaceutical Preparations